Peptide Therapeutics Market Is Increasing Due To Technological Advancements In Peptide Manufacturing Process Till 2025: Grand View Research, Inc.
The
global peptide therapeutics market is expected to reach USD 48.04
billion by 2025, according to a new report by Grand View Research, Inc.
Increasing demand for efficient & rapid-acting therapeutics for treatment
of cancer and other lifestyle-associated disorders, which result in lesser
adverse effects, are anticipated to propel market growth.
Rising
incidence of cancer calls for exploring and introducing other means of
therapies and low-cost treatment alternatives. Moreover, growing base of
geriatric population is expected to widen the consumer base by triggering
incidence rate of target diseases such as cancer & diabetes, which are
expected to drive the demand for peptide therapeutics.
Technological
advancements in peptide manufacturing process is one of the major factors
driving the market growth during the forecast period. Manufacturers and
suppliers are focusing on the adoption of novel technologies to manufacture
efficient drug molecules with low time and capital investment. Improvement in
purification & automation process and less generation of waste is an
additional factor attributing toward market growth
U.S.
peptide therapeutics market, by drug type, 2014 - 2025 (USD Million)
Browse full
research report on Peptide Therapeutics Market: http://www.grandviewresearch.com/industry-analysis/peptide-therapeutics-market
Further
key findings from the study suggest:
- Cancer held the largest market share in 2016
owing to increasing demand for alternative therapeutics over conventional
treatment options. Peptides are being used as potential therapeutic agents
in cancer treatment.
- The generic drug segment is expected to showcase
upward shift due to patent expiration of blockbuster peptides and
supportive government initiatives pertaining to the introduction of
generic class
- Outsourced manufacturing is expected to grow at
CAGR of 6.7% owing to requirements of complex procedures and shift in
preference toward outsourcing, which helps in eliminating cost of
production.
- Route of administration including nasal and
intradermal routes is expected to grow at a rapid pace owing to ease of
usage and advantages over other routes of administration such as oral.
- Hybrid technology is expected to spearhead the
growth of this market. Benefits associated with this technology such as
time conservation and ease of usage for both solid- and liquid-phase
peptide synthesis are the key factors affirming growth.
- North America held the largest share in terms
of revenue in 2016 owing to higher level of awareness pertaining to
genomics & proteomics products, well-established R&D
infrastructure, and rising funding initiatives
- Asia Pacific industry is expected to showcase
lucrative growth over the forecast period with CAGR of 11.0%. Presence of
established generic industry and API providers in this region coupled with
growing economic stability in some of the countries is expected to propel
market growth.
- Some of the key players in the peptide
therapeutics market include Eli Lilly and Company; Pfizer, Inc.; Amgen,
Inc.; Takeda Pharmaceutical Company Limited; Teva Pharmaceuticals
Industries Ltd.; Lonza Inc.; Sanofi; Bristol-Myers Squibb (BMS);
AstraZeneca PLC; GlaxoSmithKline plc (GSK); Novartis AG; and Novo Nordisk
A/S
Browse more
reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the peptide therapeutics market by
application, type, type of manufacturers, route of administration, synthesis
technology, and region:
Peptide
Therapeutics, Application Outlook (Revenue, USD Million; 2014 - 2025)
- Cancers
- Metabolic
- Cardiovascular
Disorder
- Respiratory
- GIT
- Antiinfection
- Pain
- Dermatology
- CNS
- Renal
- Others
Peptide
Therapeutics, Type Outlook (Revenue, USD Million; 2014 - 2025)
- Generic
- Innovative
Peptide
Therapeutics, Type of Manufacturers Outlook (Revenue, USD Million; 2014 - 2025)
- In-house
- Outsourced
Peptide
Therapeutics, Route of Administration Outlook (Revenue, USD Million; 2014 -
2025)
- Parenteral
Route
- Oral
Route
- Pulmonary
- Mucosal
- Others
Peptide
Therapeutics, Synthesis Technology Outlook (Revenue, USD Million; 2014 - 2025)
- Solid
Phase Peptide Synthesis (SPPS)
- Liquid
Phase Peptide Synthesis (LPPS)
- Hybrid
Technology
Peptide
Therapeutics, Regional Outlook (Revenue, USD Million; 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- Japan
- India
- Latin
America
- Mexico
- Brazil
- MEA
- South
Africa
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-peptide-therapeutics-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment